跳至主要内容
临床试验/NCT03654365
NCT03654365已完成不适用

Once Lifetime Hepatitis C (HCV) Screening Among Adults Using Advanced Electronic Population Health Tools and Personal Health Record Tools Tied to an Advanced Electronic Health Record (EHR).

MetroHealth Medical Center0 个研究点目标入组 1,024 人开始时间: 2016年11月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,024
主要终点
Impact on hepatitis C antibody testing rates at 12 weeks post direct patient messaging

研究概览

简要总结

This study involves randomizing patients due for once in a lifetime Hepatitis C screening based on Center for Disease Control and Prevention and United States Preventative Services Task Force guidelines in one of three primary care clinics within the MetroHealth System to bulk messaging and bulk ordering for HCV antibody vs usual care (routine alerting).

详细描述

All patients had to have an active personal health record account at the time of being randomized.

Patients had to have been seen by their primary care provider in the last 6 months to be eligible and therefore had a "missed opportunity" for Hepatitis C screening.

Control group received "usual care" which in our system included alert (health maintenance reminder) to the primary care provider at the time of the visit and passive alert in their personal health record (i.e. an alert if they log into their personal health record and look for reminders for preventative care that it due/overdue).

Intervention group received same care as control group plus automatic ordering of the hepatitis C screening test and active electronic letter their personal health record that they were due for hepatitis C screening, what hepatitis C is, what the testing and if positive, treatment could involve, and instruction to go to one of the laboratories in the healthcare system to have their blood drawn if they were interested in the testing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
Double (Care Provider, Investigator)

入排标准

年龄范围
51 Years 至 71 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • seen recently in one of the three primary care study sites and have an active person health record at the time of randomization; and meet Centers for Disease Control and Prevention/United States Preventative Services Task Force guidelines for once in a lifetime hepatitis C screening

排除标准

  • already had once in a lifetime screen for hepatitis C or positive for hepatitis C (by lab test or International Classification of Disease code)

结局指标

主要结局

Impact on hepatitis C antibody testing rates at 12 weeks post direct patient messaging

时间窗: 12 weeks post-intervention

Number of patients who remain untested for HCV at 12 weeks post direct patient messaging

次要结局

  • Impact of bulk ordering vs bulk messaging and bulk ordering on HCV antibody testing rates(12 weeks post-intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Kaelber MD

Physician and Chief Medical Informatics Officer

MetroHealth Medical Center

相似试验